OBJECTIVES:  To describe the healthcare services included in the patient journey, after a woman has been diagnosed with breast Ca in Greece and to identify criteria of choice between private and public healthcare providers. METHODS: A telephone survey was conducted between May – June 2015 in a sample of 252 women diagnosed with early or locally advanced breast Ca from 1/1/2011 to 31/8/2014. Participants were recruited through a patients' organization and had to have completed their therapy regimen (chemotherapy and/or radiation therapy) in order to participate. The survey questionnaire was developed based on the model of pathways to treatment and the results of a previously conducted qualitative study in 19 women. RESULTS:  All women underwent surgery, however, 7.4% of them received therapy prior to their surgery. 51.0% had total mastectomy and 49.0% had breast conserving surgery. 73.4% of participants had chemotherapy, 19.2% received treatment with biologic agents and 68% had radiation therapy. Patients were treated in a private sector provider in 57.4%, 59.0% , 38% and 47% of cases for surgery, chemotherapy, treatments with biologic agents and radiation therapy respectively. 76.5% haven’t had plastic surgery while 23.5% had undergone breast reconstruction or were in the process of doing so. 49.8% sought psychological support primarily from patients’ organizations and from private practitioners. The main criteria for choice of provider related to the quality of services provided: the treating physician (surgeon, oncologist and radiologist), specialized breast Ca units, equipment. Cost constituted a barrier to seeking psychological care. CONCLUSIONS:  Breast Ca patients choose to a large extent private sector providers in all steps of the patient journey. Given also that out-of-pocket costs are higher in the private sector, concerns can be raised about the affordability of private healthcare services and the accessibility and responsiveness of the public breast cancer healthcare services.